Therapeutic implications of the anergic/postactivated status of B cells in systemic lupus erythematosus

Systemic lupus erythematosus (SLE) is characterised by numerous abnormalities in B lineage cells, including increased CD27++ plasmablasts/plasma cells, atypical CD27-IgD- B cells with increased CD95, spleen tyrosine kinase (Syk)++, CXCR5- and CXCR5+ subsets and anergic CD11c+Tbet+ age-associated B c...

Descripción completa

Detalles Bibliográficos
Autores principales: Dörner, Thomas, Szelinski, Franziska, Lino, Andreia C, Lipsky, Peter E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Lupus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425190/
https://www.ncbi.nlm.nih.gov/pubmed/32675278
http://dx.doi.org/10.1136/rmdopen-2020-001258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425190/
https://www.ncbi.nlm.nih.gov/pubmed/32675278
http://dx.doi.org/10.1136/rmdopen-2020-001258

Ejemplares similares